Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.

Revenue
+8.28%
EPS
+36.7%
Free cash flow
+19.1%
Total debt
+44.9%

Quarter to September 2026, against a year earlier

229.63 3.29 +1.45%
Market cap
$159.2B
P/E
37.0×
Fwd P/E
36.9×
Dividend yield
0.67%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
18.80 22.80 24.08 33.05 39.46 33.12 23.65 36.40 43.07 45.15
Piotroski F-Score
7 4 8 4 6 6 7 4 7 6
P/S ratio
2.85 3.66 3.74 5.41 6.21 8.37 6.30 7.24 7.03 6.64
Altman Z-Score
2.49 2.94 3.31 3.23 3.36 4.43 4.34 4.54 4.95 4.52
Altman Z″-Score (non-manufacturers)
2.96 3.62 3.96 4.81 3.24 3.33 4.23 4.25 4.37 4.46
P/FCF ratio
16.34 19.32 18.52 29.10 25.56 29.11 22.66 29.85 31.61 30.82
Beneish M-Score
(2.57) (2.45) (2.74) (2.80) (2.22) (2.50) (2.68) (2.63) (2.73) (2.57)
P/Operating CF
74.07 68.03 51.53 87.15 62.35 88.97 66.07 106.81 83.11 77.07
Dividend Safety Score
— — — — — — — — — 69
P/B ratio
2.08 2.15 2.26 3.38 3.79 4.95 3.47 3.23 3.39 3.11
EV/Sales
3.36 4.28 4.26 5.50 6.89 9.16 6.79 7.69 7.59 7.20
EV/EBITDA
14.70 18.02 17.17 22.09 23.77 26.73 18.72 24.91 25.03 24.79
EV/FCF
19.30 22.62 21.10 29.58 28.35 31.85 24.42 31.72 34.14 33.43
Current Ratio
0.97 1.43 1.47 5.19 1.86 1.43 1.89 1.68 1.40 1.87
Net Debt/EBITDA
2.25 2.63 2.10 0.36 2.35 2.30 1.35 1.47 1.85 1.93
Debt/Equity
0.42 0.39 0.34 0.71 0.53 0.49 0.38 0.31 0.31 0.35
ROE
10.90% 10.08% 9.71% 10.33% 10.77% 15.99% 15.73% 9.31% 7.57% 7.08%
ROA
5.46% 5.42% 5.61% 5.35% 5.08% 7.87% 8.48% 5.62% 4.81% 4.49%
ROIC
5.38% 4.46% 5.14% 6.41% 4.81% 6.15% 7.45% 5.05% 4.83% 4.42%
Return on Tangible Assets
119.05% 55.23% 58.89% 12.80% 36.33% 85.90% 63.40% 46.43% 50.71% 31.48%
Average Days of Receivables
68.88 82.83 64.86 65.03 66.25 68.15 56.20 59.92 54.07 58.13
Earnings Yield
5.32% 4.39% 4.15% 3.03% 2.53% 3.02% 4.23% 2.75% 2.32% 2.21%
Free Cash Flow Yield
6.12% 5.18% 5.40% 3.44% 3.91% 3.44% 4.41% 3.35% 3.16% 3.24%
Free Cash Flow per Share
4.26 4.22 4.92 4.66 7.67 9.98 10.22 7.87 7.26 7.43
Book value per Share
33.39 37.90 40.29 42.35 56.33 63.22 69.08 72.63 67.78 73.72
Free Cash Flow
2,942.00 2,939.60 3,444.00 3,329.00 5,419.00 7,131.00 7,410.00 5,793.00 5,309.00 5,293.00
EV/EBIT
20.76 25.85 23.79 30.13 36.31 35.62 24.01 35.33 37.27 37.73
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026